Literature DB >> 20396417

Withholding statins in patients with underlying liver disease: wise or unwise?

Robert P Perrillo1.   

Abstract

Entities:  

Year:  2010        PMID： 20396417      PMCID： PMC2848084          DOI： 10.1080/08998280.2010.11928596

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  10 in total

1.  Statins and hepatic steatosis: perspectives from the Dallas Heart Study.

Authors:  Jeffrey D Browning
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

2.  Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

Authors:  James M McKenney; Michael H Davidson; Terry A Jacobson; John R Guyton
Journal:  Am J Cardiol       Date:  2006-02-28       Impact factor: 2.778

3.  Is statin therapy safe in patients with HIV/hepatitis C coinfection?

Authors:  Jeffrey S Stroup; Bryan Harris
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-04

4.  An assessment of statin safety by hepatologists.

Authors:  David E Cohen; Frank A Anania; Naga Chalasani
Journal:  Am J Cardiol       Date:  2006-02-03       Impact factor: 2.778

5.  Diagnosis, management and prevention of drug-induced liver injury.

Authors:  S Verma; N Kaplowitz
Journal:  Gut       Date:  2009-11       Impact factor: 23.059

6.  Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity.

Authors:  Naga Chalasani; Hisham Aljadhey; Joe Kesterson; Michael D Murray; Stephen D Hall
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

7.  Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study.

Authors:  Winston Dunn; Ronghui Xu; Deborah L Wingard; Christopher Rogers; Paul Angulo; Zobair M Younossi; Jeffrey B Schwimmer
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

Review 8.  Lipid-lowering agents that cause drug-induced hepatotoxicity.

Authors:  Sidharth S Bhardwaj; Naga Chalasani
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126

9.  Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study.

Authors:  Andrew L Avins; Michele M Manos; Lynn Ackerson; Wei Zhao; Rosemary Murphy; Theodore R Levin; Douglas J Watson; Peggy M T Hwang; Amy Replogle; Jeffrey G Levine
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 10.  Drug-induced liver injury associated with statins.

Authors:  Mark W Russo; Martin Scobey; Herbert L Bonkovsky
Journal:  Semin Liver Dis       Date:  2009-10-13       Impact factor: 6.115
  10 in total
  1 in total

1.  Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected Outpatients.

Authors:  Matthew E Levy; Alan E Greenberg; Manya Magnus; Naji Younes; Amanda Castel
Journal:  AIDS Patient Care STDS       Date:  2018-02       Impact factor: 5.078
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.